VEGFA and age-related macular degeneration: Given the reported association between genetic variants and various clinical phenotypes in exudative AMD [16,17,18,19,20], it is reasonable to hypothesize that genetic factors may be associated with response to intravitreal injection of VEGF inhibitors, including aflibercept.